YTHDF1 and melanoma: In YTHDF1-deficient melanoma or colon cancer, antigen cross-presentation by tumor-infiltrating DCs induces a stronger anti-cancer immune response and mature YTHDF1-deficient DCs can activate T cells more effectively than wild-type cells, leading to stronger anti-tumor immunity (125).